properties of 2-amino-4-[4-(2-hydroxyethyl)-piperazin 1-yl]-6-trifluoromethyl-s-triazine (TR-10) were investigated in mice and rats. Chlor promazine served as a reference compound.
promazine served as a reference compound.
TR-10 expressed in general the pharma cological profiles as neuroleptics ascertained by anti-methamphetamine activity, supression of conditioned avoidance response, taming effects, decrease in exploratory behavior and cataleptogenic activity. Among these effects, anti-methamphetamine action was most potent. Different from chlorpromazine, TR-10 showed a similar pharmacological activity pattern in the intraperitoneal and oral routes of adminis stration as depicted from ED50,'LD50 values. Although the effects relevant to neu roleptics were less potent than chlorpromazine, such were seen with TR-10 at lower doses than those causing muscle relaxation.
TR-10 significantly depressed the spon taneous motor activity but showed no anti-convulsant action in mice. Hypothermic action, potentiating effects of hypnotics and a-adrenergic blocking action, characteristic to chlorpromazine, were very weak for TR-10. TR-10 also showed low toxicity in mice (LD50=820 mg/kg p.o., 465 mg/kg i.p.) compared with that of chlorpromazine (LD50 =370 mg, kg p.o., 228 mg'kg i.p.).
Since the discovery of chlorpromazine (1) or haloperidol (2) , a large number of their derivatives has been synthesized and widely used for clinical treatment of schizophrenia.
Neuroleptics exhibit cataleptogenic, anti-methamphetamine (amphetamine), con ditioned avoidance response depressant and other pharmacological actions in animals and these properties are often used for predicting neuroleptic actions of the compounds (3).
In the course of investigation with triazine derivatives which possessed central nervous system depressant action (4) 
MATERIALS AND METHODS

Exploratory behavior in rats (open-field test)
The open field is a square box (100 100 cm, 40 cm in height) the bottom and wall of which were painted black. The apparatus was placed in a dark room illuminated by a 100 W lamp situated 100 cm above the central part of the field. Seven rats were used per each dose level and drugs were administered i.p. 30 min before observation. The perfor mance of the rats in the open field was observed for 3 min and the number of ambulations and rearings was calculated.
Cataleptogenic activity (9) Cataleptogenic activity in mice: Each group included 7 mice and drugs were admin istered 30 min (i.p.) or 60 min (p.o.) before testing catalepsy. Forepaws were put on a horizontal steel bar, 5 cni in height, and mice were forced to maintain an abnormal position.
When the mice could keep the same posture for over 30 sec, it was interpreted as drug effect (postive response). The ED50 was the dose that caused catalepsy in 50% of the mice treated.
Cataleptogenic activity in rats: Each group included 7 rats and the catalepsy was measured according to the method described in (I ) until 6 hr after drugs (i.p.). The height of the horizontal bar was 8 cm.
Anti-methamphetamine activity
Antagonisms of miethaliiphetamiine-indiiced hypermiotdity in mice: Six mice were used per each dose level. Methamphetamine (5 mgjkg i.p.) was administered 30 min after drugs and 30 min thereafter, the locomotor activity was measured for 10 min using an ANIMEX activity meter. The ED50 was the dose that depressed the hypermotility of the control group to 50 . Ale thammphetamiine-induced stereotyped behavior in rats (10) Each animal was assigned a stereotyped score of 0 to 6, and the description of each rating score was given as follows :
Scoring system for methamphetamine-induced stereotyped behavior. Conditioned avoidance response in rats Five rats per each dose level were used. Each rat was trained in the two-compartment shuttle box for 30 trials a day. The training schedule was as follows : a light and buzzer (80 db) was used as conditioned stimulus (CS). Five sec after CS, the grid floor on the lighted compartment was electrified for an additional 5 sec as an unconditioned stimulus (US). When the rat avoided or escaped into another compartment during CS or US, CS was again delivered 25 sec after. After 10 days training, the rat which showed more than 80 % conditioned avoidance response (CAR) was selected for the present experiments.
CAR was tested 30, 60, 120, 180 and 240 min after drugs.
Long-term isolation-induced fighting in mice
Mice were isolated in individual cages (15 x 10 x 15 cm) for 6 to 7 weeks and pairs of mice which fought with each other during 1 min period of observation were selected for use.
Mice were treated with drugs (6 pairs of mice per each dose level) and tested for fighting 
RESULTS
Acute toxicity and gross behavior in mice
As shown in Table 1 , acute toxicity of TR-10 was significantly lower than that of chlor promazine. TR-10 showed marked neurological defects such as ataxia, prostration, catalepsy and muscle relaxation without loss of righting reflex at 300 mg/kg i.p. and 600 mg/kg p.o..
At lethal doses, salivation, twitch, tremor and death due to clonic convulsion occurred. At that of chlorpromazine (Table 1) . When spontaneous motor activity was measured for 4 hr, TR-10 showed the peak depressant effect at 60 min and then gradually recoverd to the control level. In contrast, with chlorpromazine, the peak effect was seen at 30 min and depressant action continued longer than that of TR-10 ( Fig. 2) .
Exploratory behavior in rats (open field test)
As shown in Fig. 3 ., TR-10 significantly depressed exploratory behavior at the dose of 10 to 20 mg/kg i.p.. Ainbulation was somewhat more strongly depressed than rearing.
Chlorpromazine almost equally depressed ambulation and rearing at 2.5 to 5 mg/kg i.p..
Cataleptogenic activity
Cataleptogenic activity in mice: As shown in Table 1 , moderate catalepsy in mice was evident after TR-10 and the ED50 was 14 mg/kg i.p. and 27 mg/kg p.o.. At this dose level of TR-10, there was no muscle relaxation while the cataleptogenic activity of chlor promazine was accompanied by significant muscle relaxation.
Cataleptogenic activity in rats: As illustrated in Table 2 , TR-10 revealed a weak and delayed onset of cataleptogenic activity compared with that of chlorpromazine. The peak effect of TR-10 was observed at 3 hr after the injection. Six hr after TR-10, moderate catalepsy occurred only with high doses (45 mg/kg i.p.) and control levels were reverted to after 8 hr. With chlorpromazine, the peak effect was seen at 4 hr after administration and the effect continued longer than that of TR-10.
Anti-methamphetamine activity
Antagonism of nmethamphetamnine-inchuced hypermotility in mice: As described in Table 1 
Long-term isolation-induced fighting in mice
As shown in Table 3 , the ED50 values were determined at 30, 60 and 120 min after drugs. TR-10 expressed the lowest ED50 value at 120 min (7.0 mg/kg i.p., 16 mg/kg p.o.), while chlorpromazine showed the peak depressant effect at 60 min. The depressant activity of chlorpromazine was considered to be 4 to 5 times more potent than that of TR-10.
Footshock-induced fighting in mice
Depressant effect of TR-10 for footshock-induce fighting was to some extent weak (Table 1) .
Muscle relaxant action (Traction test in mice)
As shown in Table 1 , TR-10 expressed considerably weak muscle relaxant action with the traction test. The ED50 of TR-10 was 40 mg/kg i.p. and 82 mg/kg p.o., respectively.
Chlorpromazine, however, had 10 (i.p.) and 4 (p.o.) times a more potent relaxant activity than that of TR-10.
Hypothermic action in mice 
Pentobarbital sleeping time prolongation effect
As shown in Table 4 , with TR-10 there was a less potentiating effect of pentobarbital than with chlorpromazine. Chlorpromazine had a significant potentiating effect at 2.5 to 5 mg/kg i.p., while with TR-10, doses of 30 mg/kg or over were required to obtain the same effects. 
Maximal electroshock convulsion in mice
Neither TR-10 nor chlorpromazine had a protective effect against maximal electroshock convulsion at 50 to 100 mg/kg p.o.. Acetic acid-induced writhing in mice TR-10 depressed the writhing syndrome at comparatively low doses as described in Table 5 . Chlorpromazine also had a potent depressant effect and the potency was about 4 times that of TR-10.
a-adrenergic blocking activity in isolated vas deferens of guinea pig.
TR-10 showed no antagonism against adrenaline-induced contraction of the vas deferens at 10 to 10-4 g/ml. Chlorpromazine depressed the adrenaline-induced contraction from 10-9 g/ml and the 50 % inhibitory concentration (ED50) was 2.2 x 10-8 g/ml.
DISCUSSION
Pharmacological properties of TR-10, a new compound not chemically related to existing classes of psychoactive drugs, were investigated in comparison with those of chlor promazine.
As shown in Fig. 7 ., pharmacological activity pattern (ED50/LD50) of TR-10 was characterized by weak muscle relaxant action and close resemblance of the pattern between oral and intraperitoneal routes of administration, while in the case of chlorpromazine, there were considerable differences and pharmacological activity with intraperitoneal admin FIG. 7. Pharmacological activity pattern of TR-10 and chlorpromazine in mice.
•--®: oral administration, intraperitoneal administration. SMA : spontaneous motor activity. Pharmacological activity of each test is shown as a ratio of ED50/LD50. istration was many times more potent than with oral administration.
These results indicate that TR-10 is more readily absorbed by the oral route.
Anti-methamphetamine action (anti-amphetamine action) is one of the notable char acteristics of neuroleptics and the stereotyped behavior induced by methamphetamine or amphetamine is considered to be closely related to the dopaminergic mechanism (13) in the central nervous system. TR-10 showed a pronounced depressant action against metham phetamine-induced hypermotility in mice and stereotyped behavior in rats. While the activity in mice was 0.6 to 0.7 times that of chlorpromazine, TR-10 exhibited anti-metham phetamine action with considerably lower dose levels than that causing muscle relaxation. The ratio of ED50-traction test to ED50-anti-methamphetamine action was 4.5 for TR-10 and 0.57 for chlorpromazine by the intraperitoneal route, 3.4 for TR-10 and 1.5 for chlor promazine by the oral route, respectively.
Most neuroleptics induced catalepsy in animals and this property is frequently used for evaluating the neuroleptic action (14) . TR-10 resulted in catalepsy in mice and the potency was 0.7 (p.o., 60 min) and 0.3 (i.p., 30 min) times that of chlorpromazine. In contrast to the results in mice, TR-10 had a weak and delayed onset of cataleptogenic effect in rats. Since catalepsy in rats more than in mice is considered to be closely related to clinical effects (15) and potent cataleptogenic action often reflects severe extrapyramidal side effects (16), TR-10 appears to have better properties as a neuroleptic.
Chlorpromazine depressed the conditioned avoidance response and the exploratory behavior at lower doses than those which depressed methamphetamine-induced stereotyped behavior. Conditioned avoidance response and exploratory behavior were also depressed by TR-10 but higher doses were required in comparison with the effective doses of anti methamphetamine action. Although conditioned avoidance response depressant action is considered specific for neuroleptics (17) , newly synthesized compounds exhibited weak or little depressant action against conditioned avoidance response in spite of possessing anti-schizophrenic clinical effects. One such case is Sch 12679 (18) , and the other is clozapine (19) . Sch 12679 is actually devoid of depressant action and clozapine is effective only at the doses causing muscle relaxation. Although the type of action of TR-10 is considered to be different from that of chlorpromazine or other new compounds, the aforementioned reports indicate that a mild conditioned avoidance response depressant action of TR-10
does not always mean a weak anti-psychotic effect.
TR-10 also depressed fighting in isolated mice and the foot-shock-induced fighting in mice. Inhibitory effect of TR-10 for foot-shock-induced fighting was to some extent weak compared with the marked taming effect seen in isolated mice. These properties which coincide with spontaneous motor activity depressant effects, indicate that TR-10 has a mild anti-anxiety or sedative action.
Other pharmacological properties characteristic to chlorpromazine are potent muscle relaxant, hypothermic, hypnotic potentiating and a-adrenergic blocking actions. Chlor promazine strongly revealed these effects at the dose level which expressed neuroleptic action. On the other hand, TR-10 showed weak actions as a muscle relaxant and also had weak hypnotic potentiating effects. Hypothermic action was only slightly observed at 40 mg/kg i.p. and a-adrenergic blocking action was not observed. The LD50 value of TR-10 was about twice that of chlorpromazine. In view of the present results, TR-10 is con sidered to be a neuroleptic with moderate sedative effect and weak side effects.
